Home › Markets › Health Care › MDWD

MediWound Ltd. (MDWD)

MDWD trades on Nasdaq in Health Care, Medicinal Chemicals and Botanical Products . Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$12.22
-2.71% on the day
Market cap
$157.8M
Micro cap
Revenue · 2025
$17.0M
No prior year to compare
Net income · 2025
-$23.9M
-140.8% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC 20-F (ifrs-full:Revenue), period ending 2025-12-31, https://www.sec.gov/Archives/edgar/data/1593984/000117891326000749/0001178913-26-000749-index.htm. Net income: SEC 20-F (ifrs-full:ProfitLoss), period ending 2025-12-31.

Profile

FieldValue
TickerMDWD on Nasdaq
SectorHealth Care
Industry Medicinal Chemicals and Botanical Products
CountryIsrael
IPO year2014
SEC CIK0001593984
SEC industry codeMedicinal Chemicals & Botanical Products
Incorporated inL3

Financials · 2025

LineValue
Revenue$17.0M
Net income-$23.9M
Operating incomeNot in SEC XBRL data
Net margin-140.8%
Operating marginOperating income not reported
Revenue growthNo prior-year revenue to compare
CashNot in SEC XBRL data
Total assetsNot in SEC XBRL data
P/E (computed)Net income was not positive
P/S (computed)9.3×

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52025-09-30
Latest annual report20-F2026-03-05
Latest quarterly / interim6-K2026-08-13

Source: SEC EDGAR submissions feed, 393 recent filings. All filings on EDGAR.

Peers in Medicinal Chemicals and Botanical Products

TickerCompanyPriceDayMarket cap
NAGENiagen Bioscience Inc.$2.58-1.90%$204.1M
ACBAurora Cannabis Inc. Common Shares$4.29-1.38%$265.8M
SNDLSNDL Inc. Common Shares$1.16-0.85%$285.5M
USNAUSANA Health Sciences Inc.$15.46+3.41%$285.6M
FTLFFitLife Brands Inc.$9.07-1.73%$85.2M
ISPRIspire Technology Inc.$1.45-1.36%$83.7M
CGCCanopy Growth Corporation Common Shares$0.7625+0.66%$322.6M
GLASGlass House Brands Inc. Subordinate Voting Shares$3.85-5.64%$338.8M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier